Alpha Mark Advisors, LLC Infinity Pharmaceuticals, Inc. Transaction History

Alpha Mark Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$0.82 - $1.34 $9,912 - $16,199	-12,089 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$0.77 - $1.13 $2,425 - $3,559	3,150 Added 35.24%	12,089 $11,000
Q1 2020 Apr 24, 2020	BUY	$0.69 - $1.52 $1,199 - $2,643	1,739 Added 24.15%	8,939 $7,000
Q4 2019 Feb 07, 2020	BUY	$0.88 - $1.29 $2,640 - $3,870	3,000 Added 71.43%	7,200 $7,000
Q3 2019 Nov 01, 2019	BUY	$1.03 - $1.75 $1,030 - $1,750	1,000 Added 31.25%	4,200 $4,000
Q1 2019 May 09, 2019	BUY	$1.18 - $1.91 $3,776 - $6,112	3,200 New	3,200 $6,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Mark Advisors, LLC with notifications on news.